JP2017534591A5 - - Google Patents

Download PDF

Info

Publication number
JP2017534591A5
JP2017534591A5 JP2017516735A JP2017516735A JP2017534591A5 JP 2017534591 A5 JP2017534591 A5 JP 2017534591A5 JP 2017516735 A JP2017516735 A JP 2017516735A JP 2017516735 A JP2017516735 A JP 2017516735A JP 2017534591 A5 JP2017534591 A5 JP 2017534591A5
Authority
JP
Japan
Prior art keywords
alkyl
compound according
aryl
heteroaryl
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017516735A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017534591A (ja
JP6770511B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/052611 external-priority patent/WO2016053855A1/en
Publication of JP2017534591A publication Critical patent/JP2017534591A/ja
Publication of JP2017534591A5 publication Critical patent/JP2017534591A5/ja
Application granted granted Critical
Publication of JP6770511B2 publication Critical patent/JP6770511B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017516735A 2014-09-29 2015-09-28 心肺障害の処置のためのスフィンゴシン−1−リン酸受容体モジュレーター Expired - Fee Related JP6770511B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462056946P 2014-09-29 2014-09-29
US62/056,946 2014-09-29
PCT/US2015/052611 WO2016053855A1 (en) 2014-09-29 2015-09-28 Sphingosine-1-phospate receptor modulators for treatment of cardiopulmonary disorders

Publications (3)

Publication Number Publication Date
JP2017534591A JP2017534591A (ja) 2017-11-24
JP2017534591A5 true JP2017534591A5 (cg-RX-API-DMAC7.html) 2018-10-25
JP6770511B2 JP6770511B2 (ja) 2020-10-14

Family

ID=55631308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017516735A Expired - Fee Related JP6770511B2 (ja) 2014-09-29 2015-09-28 心肺障害の処置のためのスフィンゴシン−1−リン酸受容体モジュレーター

Country Status (13)

Country Link
US (2) US10323029B2 (cg-RX-API-DMAC7.html)
EP (1) EP3209732B1 (cg-RX-API-DMAC7.html)
JP (1) JP6770511B2 (cg-RX-API-DMAC7.html)
KR (1) KR102307037B1 (cg-RX-API-DMAC7.html)
CN (1) CN107001806B (cg-RX-API-DMAC7.html)
AU (1) AU2015324163B2 (cg-RX-API-DMAC7.html)
CA (1) CA2962922C (cg-RX-API-DMAC7.html)
EA (1) EA031503B1 (cg-RX-API-DMAC7.html)
ES (1) ES2895174T3 (cg-RX-API-DMAC7.html)
IL (1) IL251387B (cg-RX-API-DMAC7.html)
SG (1) SG11201702483QA (cg-RX-API-DMAC7.html)
WO (1) WO2016053855A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201702403B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2895174T3 (es) 2014-09-29 2022-02-17 Scripps Research Inst Moduladores del receptor de esfingosina-1-fosfato para el tratamiento de trastornos cardiopulmonares
WO2017144183A1 (en) * 2016-02-24 2017-08-31 Acesion Pharma Aps Novel potassium channel inhibitors
US11049009B2 (en) * 2017-06-12 2021-06-29 Western Digital Technologies, Inc. Identifying memory block write endurance using machine learning
CN111107845A (zh) * 2017-09-29 2020-05-05 诺华股份有限公司 西尼莫德的给药方案
EP3790861A4 (en) * 2018-07-11 2022-03-30 Rubedo Life Sciences, Inc. SENOLYTIC COMPOSITIONS AND THEIR USES
KR102218280B1 (ko) * 2019-01-30 2021-02-22 주식회사 엑세쏘바이오파마 P1p 유도체의 패혈증 치료제 용도
JP7667573B2 (ja) * 2019-05-03 2025-04-23 プラクシス プレシジョン メディシンズ, インコーポレイテッド Kcnt1阻害剤および使用する方法
CN113200971B (zh) * 2021-05-14 2022-06-28 济南大学 一类具有芳香基哌嗪结构的吲哚恶二唑衍生物的合成和应用
CA3220146A1 (en) * 2021-05-17 2022-11-24 Hk Inno.N Corporation Benzamide derivatives, preparation method thereof, and pharmaceutical composition for use in preventing of treating cancer containing the same as an active ingredient
WO2025176104A1 (en) 2024-02-19 2025-08-28 Ono Pharmaceutical Co., Ltd. Heterocyclic derivatives having s1p3 receptor antagonistic activity

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2085736A (en) * 1933-12-06 1937-07-06 Du Pont Compounds of the triphenylmethane series
US3217012A (en) * 1960-10-26 1965-11-09 Purdue Research Foundation Substituted pyridines, process for and new compositions
US3916000A (en) * 1971-07-21 1975-10-28 Commw Scient Ind Res Org Alkylation process
EP0355864A3 (en) * 1984-03-15 1991-09-18 Wako Pure Chemical Industries, Ltd. Method of quantitatively measuring an oxidative substance by using triphenyl methane type leuco compounds as coloring matter
US6028103A (en) 1994-09-16 2000-02-22 Children's Medical Center Corporation Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
US20020156301A1 (en) * 1997-06-17 2002-10-24 Sumitomo Chemical Co., Ltd. Triphenylmethane derivatives and use thereof
DE60330047D1 (en) * 2002-01-18 2009-12-24 Merck & Co Inc "n-(benzyl)aminoalkyl carboxylate, phosphinate, phosphonate und tetrazole als edg rezeptoragonisten"
US20060287537A1 (en) * 2003-08-27 2006-12-21 Stanislav Radl Method of removing the triphenylmethane protecting group
US7888376B2 (en) * 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101528699A (zh) * 2005-11-23 2009-09-09 布里斯托尔—迈尔斯斯奎布公司 杂环胆固醇酯转运蛋白抑制剂
AU2007286659A1 (en) * 2006-08-23 2008-02-28 Wyeth 8-Hydroxyquinoline Compounds and methods thereof
WO2009027392A1 (en) 2007-08-27 2009-03-05 Abbott Gmbh & Co. Kg 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
AU2009225869B2 (en) * 2008-03-18 2014-01-23 Merck Sharp & Dohme Llc Substituted 4-hydroxypyrimidine-5-carboxamides
AU2009249237A1 (en) 2008-05-19 2009-11-26 Schering Corporation Bicyclic heterocycle derivatives and use thereof as GPR119 modulators
WO2010014948A1 (en) * 2008-08-01 2010-02-04 The University Of Utah Research Foundation Methods of treatment using wnt inhibitors
WO2010056758A1 (en) * 2008-11-12 2010-05-20 Yangbo Feng Quinazoline derivatives as kinase inhibitors
JP2013028538A (ja) * 2009-11-13 2013-02-07 Dainippon Sumitomo Pharma Co Ltd 新規アミド誘導体
CN103338764A (zh) * 2010-12-03 2013-10-02 阿勒根公司 作为鞘氨醇1-磷酸(s1p)受体调节剂的新型氮杂环丁烷衍生物
RU2013130020A (ru) * 2010-12-03 2015-01-10 Аллерган, Инк. Производные оксадиазола в качестве модуляторов рецептора сфингозин 1-фосфата (s1p)
RU2013130023A (ru) 2010-12-03 2015-01-10 Аллерган, Инк. Новые производные пиридина в качестве модуляторов рецептора сфингозин 1-фосфата (s1p)
BR112013033316A2 (pt) * 2011-06-24 2017-01-31 Amgen Inc antagonista de trpm8 e seu uso em tratamentos
US20130272962A1 (en) * 2012-04-11 2013-10-17 Fluoron Gmbh Staining agent for corneal staining
US9410058B2 (en) 2014-04-10 2016-08-09 United States Gypsum Company Compositions and methods for water-resistant gypsum fiber products
ES2895174T3 (es) 2014-09-29 2022-02-17 Scripps Research Inst Moduladores del receptor de esfingosina-1-fosfato para el tratamiento de trastornos cardiopulmonares

Similar Documents

Publication Publication Date Title
JP2017534591A5 (cg-RX-API-DMAC7.html)
TWI400234B (zh) 作為組織胺h4受體調節劑之苯并咪唑-2-基嘧啶類及吡類
JP2020531422A5 (cg-RX-API-DMAC7.html)
JP2013523802A5 (cg-RX-API-DMAC7.html)
JP2012507522A5 (cg-RX-API-DMAC7.html)
JP2016515096A5 (cg-RX-API-DMAC7.html)
JP2020510015A5 (cg-RX-API-DMAC7.html)
JP2015532287A5 (cg-RX-API-DMAC7.html)
JP2016516699A5 (cg-RX-API-DMAC7.html)
JP2018534348A5 (cg-RX-API-DMAC7.html)
JP2016530259A5 (cg-RX-API-DMAC7.html)
JPWO2022016070A5 (cg-RX-API-DMAC7.html)
JP2011523412A5 (cg-RX-API-DMAC7.html)
JP2016500111A5 (cg-RX-API-DMAC7.html)
JP2019524883A5 (cg-RX-API-DMAC7.html)
JP2016529306A5 (cg-RX-API-DMAC7.html)
JP2015526411A5 (cg-RX-API-DMAC7.html)
JP7644823B2 (ja) ピリドン多環縮合環系誘導体及びその使用
JP2016511753A5 (cg-RX-API-DMAC7.html)
JP2017506666A5 (cg-RX-API-DMAC7.html)
JP2014097964A5 (cg-RX-API-DMAC7.html)
JP2018528182A (ja) 6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジオール及び6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジアミンを調製する方法
JP2019505529A5 (cg-RX-API-DMAC7.html)
JP2015509075A5 (cg-RX-API-DMAC7.html)
JP2017537886A5 (cg-RX-API-DMAC7.html)